Breaking News Instant updates and real-time market news.

ABBV

AbbVie

$60.34

-0.81 (-1.32%)

16:09
10/14/16
10/14
16:09
10/14/16
16:09

AbbVie VP, controller Hurwich to resign, retire

AbbVie said in a regulatory filing that vice president and controller Thomas A. Hurwich has informed the company that he will resign effective February 28, 2017. He intends to retire from the company later in 2017. Robert A. Michael has been appointed vice president, controller, effective March 1, 2017.

  • 15

    Oct

  • 28

    Oct

ABBV AbbVie
$60.34

-0.81 (-1.32%)

09/08/16
JPMS
09/08/16
DOWNGRADE
Target $73
JPMS
Neutral
AbbVie downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Chris Schott downgraded AbbVie (ABBV) to Neutral citing the stock's 10% rally year-to-date and limited near-term catalysts. AbbVie's profile is now better reflected at current valuation levels, Schott tells investors in a research note. He lowered his price target for the shares to $73 from $75. The analyst coupled the downgrade with an upgrade this morning of Eli Lilly (LLY) to Overweight.
10/03/16
LEER
10/03/16
NO CHANGE
LEER
Market Perform
AASLD abstracts hint at potential competitive threat to Gilead HCV, says Leerink
Leerink analyst Geoffrey Porges says abstracts for the American Association for the Study of Liver Diseases, or AASLD, meeting revealed very limited efficacy information about the new Hepatitis C regimens for Gilead (GILD), Merck (MRK) and AbbVie (ABBV). Nonetheless, the analyst believes the abstracts hint at the potential competitive threat to Gilead's HCV dominance. While the new 12-week HCV regimens may compete on price, the forthcoming 8-week regimens put the most pressure on Gilead's market share, Porges argues. He reiterates a Market Perform rating on Gilead's shares.
10/12/16
RBCM
10/12/16
NO CHANGE
RBCM
Outperform
Vertex competitor to report data soon, but has long way to go, says RBC Capital
RBC Capital analyst Michael Yee noted that Galapagos NV (GLPG) and partner AbbVie (ABBV) are likely to present new Phase IIa data for GLP-1837 for cystic fibrosis and host an analyst event on October 27, adding that he believes the data will likely be positive and suggest they are "on track" with progress on their triple pill. Yee adds it won't be surprising if Galapagos has positive '1837 "potentiator" data, as this is the easier of the components and only the first piece of a 3-pill drug. Vertex (VRTX) is also hosting an analyst event on Oct. 27 and will probably also give an update on its own "triple," said Yee, who thinks it should stay in the lead with most advanced triple. Yee keeps an Outperform rating on Vertex shares.
10/13/16
JEFF
10/13/16
DOWNGRADE
Target $36
JEFF
Hold
Pfizer downgraded to Hold from Buy at Jefferies
Jefferies analyst Jeffrey Holford downgraded Pfizer (PFE) to Hold citing a lack of positive catalysts. The analyst says the drivers for his upgrade to Buy have either played out or have not materialized, namely an inversion or GEP unit separation. To reflect the infusion business disposal and weaker Ibrance trends, Holford cut his mid-term earnings estimates for Pfizer by up to 7% and cut his price target for the shares to $36 from $39. The stock closed yesterday down 6c to $33.07. The analyst also sees increased risk of a major acquisition occurring over the next 12 months. In the global pharma space, Holford lists AbbVie (ABBV), Eli Lilly (LLY), Novartis (NVS) and AstraZeneca (AZN) as his top picks.

TODAY'S FREE FLY STORIES

BNFT

Benefitfocus

$30.85

0.9 (3.01%)

16:40
04/27/17
04/27
16:40
04/27/17
16:40
Earnings
Benefitfocus sees Q2 EPS (16c)-(13c), consensus (13c) »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

IRET

Investors Real Estate

$6.07

-0.09 (-1.46%)

16:40
04/27/17
04/27
16:40
04/27/17
16:40
Hot Stocks
Investors Real Estate announces CEO, senior management changes »

IRET, in a continuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$37.65

0.34 (0.91%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
SS&C sees Q2 adjusted revenue $408M-$416M, consensus $412.69M »

Sees Q2 adjusted net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

MSTR

MicroStrategy

$192.49

-0.52 (-0.27%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
MicroStrategy reports Q1 GAAP EPS $1.28, may not compare to consensus $1.47 »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

ECOL

US Ecology

$48.45

-0.25 (-0.51%)

16:39
04/27/17
04/27
16:39
04/27/17
16:39
Earnings
US Ecology backs FY17 EPS $1.69-$1.93, consensus $1.79 »

"Overall, business…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

SSNC

SS&C

$37.65

0.34 (0.91%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
SS&C reports Q1 adjusted EPS 44c, consensus 44c »

Reports Q1 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 20

    Jun

  • 21

    Jun

  • 22

    Jun

  • 22

    Jun

INVA

Innoviva

$12.59

-0.26 (-2.02%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Innoviva reports Q1 adjusted EPS 19c, consensus 26c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

BNFT

Benefitfocus

$30.85

0.9 (3.01%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Benefitfocus reports Q1 EPS (11c), consensus (13c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

SRPT

Sarepta

$34.72

-0.14 (-0.40%)

16:38
04/27/17
04/27
16:38
04/27/17
16:38
Earnings
Sarepta raises FY17 revenue from above $80M to above $95M, consensus $97.78M »

"Based on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOL

US Ecology

$48.45

-0.25 (-0.51%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Earnings
US Ecology reports Q1 EPS 24c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

GOOGL

Alphabet Class A

$891.44

2.3 (0.26%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Hot Stocks
Alphabet Class A shares rise 5% to $935 after earnings beat »

Alphabet Class A shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIQUY

Air Liquide

$24.16

-0.23 (-0.94%)

, LECO

Lincoln Electric

$89.58

-0.71 (-0.79%)

16:37
04/27/17
04/27
16:37
04/27/17
16:37
Hot Stocks
Air Liquide to sell welding unit to Lincoln Electric France »

Air Liquide (AIQUY)…

AIQUY

Air Liquide

$24.16

-0.23 (-0.94%)

LECO

Lincoln Electric

$89.58

-0.71 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

16:37
04/27/17
04/27
16:37
04/27/17
16:37
General news
Money Supply M2 Weekly Change data reported »

Week of 4/17 Money Supply…

16:36
04/27/17
04/27
16:36
04/27/17
16:36
General news
Fed Balance Sheet Level data reported »

Week of 4/26 Fed Balance…

RMD

ResMed

$72.85

1.1 (1.53%)

16:36
04/27/17
04/27
16:36
04/27/17
16:36
Earnings
ResMed reports Q3 non-GAAP EPS 71c, consensus 71c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 06

    Jun

HEP

Holly Energy

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Holly Energy raises quarterly distribution 7.8% to 62c per unit »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BIDU

Baidu

$187.86

1.19 (0.64%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Baidu reports 451,000 active online marketing customers in Q1 »

Representing a 23.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Earnings
Breaking Earnings news story on MobileIron »

MobileIron backs FY17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

LPLA

LPL Financial

$38.52

-0.84 (-2.13%)

16:35
04/27/17
04/27
16:35
04/27/17
16:35
Hot Stocks
Breaking Hot Stocks news story on LPL Financial »

LPL Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 17

    May

MSFT

Microsoft

$68.27

0.44 (0.65%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Nadella says Q1 results reflect 'trust' in Microsoft Cloud »

"Our results this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 02

    May

  • 09

    May

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
MobileIron sees Q2 revenue $42.5M-$44.5M, consensus $43.83M »

Non-GAAP gross margin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

BIDU

Baidu

$187.86

1.19 (0.64%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Baidu CFO Jennifer Li to step down »

Baidu also announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

URBN

Urban Outfitters

$23.15

-0.55 (-2.32%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Urban Outfitters announces changes to store leadership »

Urban Outfitters, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INT

World Fuel Services

$36.79

-0.31 (-0.84%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
World Fuel Services reports Q1 adjusted EPS 64c, consensus 49c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Inter Parfums says doesn't expect Q1-type growth in remaining quarter »

""First quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.